Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Change in Acquisitions & Divestments (2021 - 2023)

InspireMD posted quarterly Change in Acquisitions & Divestments of $6.5 million for Q3 2023, down 35.0% year-on-year from $10.0 million in Q3 2022, and up 30.0% on a QoQ basis from $5.0 million in Q2 2023.

InspireMD (NSPR) has 3 years of Change in Acquisitions & Divestments data on file, last reported at $6.5 million in Q3 2023.

  • For the quarter ending Q3 2023, Change in Acquisitions & Divestments fell 35.0% year-over-year to $6.5 million; the trailing twelve-month figure through Dec 2023 stood at $18.5 million (down 33.93% YoY), and the FY2023 full-year result was $18.5 million, down 33.93% from the prior year.
  • Change in Acquisitions & Divestments for Q3 2023 stood at $6.5 million, up from $5.0 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $10.0 million in Q3 2022 and bottomed at -$22.0 million in Q4 2021.
  • The 3-year median for Change in Acquisitions & Divestments is $6.0 million (2022), against an average of $3.1 million.
  • The widest annual swing landed in 2022, when Change in Acquisitions & Divestments surged 127.27%; it then sank 35.0% in 2023.
  • A 3-year view of Change in Acquisitions & Divestments shows it stood at -$22.0 million in 2021, then soared by 127.27% to $6.0 million in 2022, then grew by 8.33% to $6.5 million in 2023.
  • The last three Change in Acquisitions & Divestments figures came in at $6.5 million (Q3 2023), $5.0 million (Q2 2023), and $7.0 million (Q1 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 InspireMD 64.01 Mn 9.80 Mn 1.18 Mn

Historic Data

Download Data 🔒
DateValue
Sep 30, 2023 6.50 Mn
Sep 30, 2023 6.50 Mn
Jun 30, 2023 5.00 Mn
Jun 30, 2023 5.00 Mn
Mar 31, 2023 7.00 Mn
Mar 31, 2023 7.00 Mn
Dec 31, 2022 6.00 Mn
Dec 31, 2022 6.00 Mn
Sep 30, 2022 10.00 Mn
Sep 30, 2022 10.00 Mn
Jun 30, 2022 6.00 Mn
Jun 30, 2022 6.00 Mn
Mar 31, 2022 6.00 Mn
Mar 31, 2022 6.00 Mn
Dec 31, 2021 -22.00 Mn
Dec 31, 2021 -22.00 Mn